Patient data from routinely collected medical records complement evidence from SGLT2 inhibitor outcome trials
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- July 2020
has subject area
- 1101 Medical Biochemistry and Metabolomics (FoR)
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Cardiovascular Diseases (MeSH)
- Cohort Studies (MeSH)
- Humans (MeSH)
- Medical Records (MeSH)
- Sodium-Glucose Transporter 2 (MeSH)
- Sodium-Glucose Transporter 2 Inhibitors (MeSH)